arrow
M

Mark R. Bray

university health network toronto
H指数:30
被引数:4,181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
LEUKEMIA
IF13.4
2023-12-193
PRE
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity
2023-02-1719
PRE
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations

纺锤体组装检查点是具有有丝分裂畸变的CDK4/6抑制剂抗性ER乳腺癌的治疗脆弱性

2022-09-0921
OAAI
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma

CFI-402257,一种TTK抑制剂,有效抑制肝细胞癌

2022-08-0131
OAAI